Detalles de la búsqueda
1.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer;
130(8): 1270-1280, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38153814
2.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer;
129(11): 1704-1713, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36932983
3.
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study.
Hematol Oncol;
41(5): 817-827, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415412
4.
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.
Eur J Haematol;
110(4): 354-361, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36480004
5.
Management of polycythemia vera: A survey of treatment patterns in Italy.
Eur J Haematol;
110(2): 161-167, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319575
6.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer;
128(13): 2449-2454, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363892
7.
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study.
Br J Haematol;
198(5): 847-860, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819919
8.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol;
197(2): 190-200, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137397
9.
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Cancer;
127(15): 2657-2665, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794557
10.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Br J Haematol;
193(2): 356-368, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33222197
11.
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
Ann Hematol;
99(1): 65-72, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31832751
12.
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.
Anticancer Drugs;
31(1): 67-72, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31633499
13.
Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review.
Int J Mol Sci;
21(11)2020 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32486130
14.
Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
Hematol Oncol;
42(1): e3247, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287530
15.
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.
Ann Hematol;
98(8): 1933-1936, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31201513
16.
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.
Br J Haematol;
182(5): 701-704, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984826
17.
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
Qual Life Res;
27(6): 1545-1554, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29520559
18.
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma.
Ann Hematol;
96(4): 627-637, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28130574
19.
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Support Care Cancer;
25(3): 839-845, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27812763
20.
Secondary syphilis mimicking malignancy: A case report and review of literature.
J Infect Chemother;
23(8): 576-578, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28456488